HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,468,126 | -25.1% | 41,720 | -30.5% | 0.00% | – |
| Q1 2023 | $1,960,013 | -89.1% | 60,031 | -81.6% | 0.00% | -100.0% |
| Q4 2022 | $17,957,091 | +19.9% | 325,900 | -3.6% | 0.00% | +33.3% |
| Q3 2022 | $14,973,000 | -31.8% | 338,072 | -24.9% | 0.00% | -25.0% |
| Q2 2022 | $21,949,000 | +161.7% | 450,058 | +161.1% | 0.00% | +300.0% |
| Q1 2022 | $8,387,000 | +224.1% | 172,400 | +184.0% | 0.00% | – |
| Q4 2021 | $2,588,000 | +100.5% | 60,694 | +70.0% | 0.00% | – |
| Q4 2020 | $1,291,000 | -54.4% | 35,711 | -57.3% | 0.00% | -100.0% |
| Q3 2020 | $2,833,000 | – | 83,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |